Snowden Capital Advisors »

Karyopharm Therapeutics shares owned by Snowden Capital Advisors

Quarter-by-quarter ownership of Karyopharm Therapeutics (KPTI) shares owned by Snowden Capital Advisors from 13F filings

Historical chart of Snowden Capital Advisors investment in Karyopharm Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Karyopharm Therapeutics held by Snowden Capital Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Karyopharm Therapeutics by Snowden Capital Advisors

Quarter filed Position value Share count Share price at filing
2023-12-31 $9.5k 11k 0.87
2023-06-30 $29k 16k 1.79
2023-03-31 $63k 16k 3.89
2022-12-31 $48k 14k 3.40
2022-09-30 $66k 12k 5.41
2022-06-30 $55k 12k 4.51
2022-03-31 $90k 12k 7.32
2021-12-31 $26k 4.1k 6.35
2019-06-30 $6.0k 21k 0.29